Marmarali, B. Et Al. 2013. THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY. VALUE IN HEALTH , vol.16, no.3 .

Marmarali, B., Ozdemir, O., Bozkurt, K., Demir, M., Ince, B., Kultursay, H., ... Ongen, G.(2013). THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY. VALUE IN HEALTH , vol.16, no.3.

Marmarali, B. Et Al. "THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY," VALUE IN HEALTH , vol.16, no.3, 2013

Marmarali, B. Et Al. "THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY." VALUE IN HEALTH , vol.16, no.3, 2013

Marmarali, B. Et Al. (2013) . "THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY." VALUE IN HEALTH , vol.16, no.3.

@article{article, author={B. Marmarali Et Al. }, title={THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY}, journal={VALUE IN HEALTH}, year=2013}